CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tebuconazole
Accession: CHEBI:81781
browse the term
Definition: A racemate composed of equimolar amounts of (R)- and (S)-tebuconazole. A fungicide effective against various smut and bunt diseases in cereals and other field crops.
Synonyms: exact_synonym: rac-1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol
related_synonym: (RS)-1-p-chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol; Ethyltrianol; Fenetrazole; Terbuconazole
alt_id: CHEBI:83566
xref: CAS:107534-96-3; KEGG:C18489
xref_mesh: MESH:C087114
xref: PMID:24200952; PMID:24522828; PMID:24920897; PMID:25300182; Pesticides:tebuconazole; Reaxys:6686475; Wikipedia:Tebuconazole
G
1700001O22Rik
RIKEN cDNA 1700001O22 gene
decreases expression
ISO
tebuconazole results in decreased expression of C9ORF50 mRNA
CTD
PMID:30458266
NCBI chr 2:30,685,575...30,695,101
Ensembl chr 2:30,684,781...30,693,673
G
1700037C18Rik
RIKEN cDNA 1700037C18 gene
decreases expression
ISO
tebuconazole results in decreased expression of C16ORF90 mRNA
CTD
PMID:30458266
NCBI chr16:3,723,662...3,726,553
Ensembl chr16:3,713,043...3,726,553
G
2210408I21Rik
RIKEN cDNA 2210408I21 gene
decreases expression
ISO
tebuconazole results in decreased expression of KIAA0825 mRNA
CTD
PMID:30458266
NCBI chr13:77,283,636...77,761,904
Ensembl chr13:77,283,659...77,761,903
G
A2ml1
alpha-2-macroglobulin like 1
decreases expression
ISO
tebuconazole results in decreased expression of OVOS2 mRNA
CTD
PMID:30458266
NCBI chr 6:128,516,785...128,577,014
Ensembl chr 6:128,516,784...128,558,571
G
Abcb11
ATP-binding cassette, sub-family B member 11
multiple interactions decreases activity
ISO
tebuconazole promotes the reaction [propiconazole results in decreased expression of ABCB11 mRNA] tebuconazole results in decreased activity of ABCB11 protein
CTD
PMID:36291160
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Abcc3
ATP-binding cassette, sub-family C member 3
decreases expression
ISO
tebuconazole results in decreased expression of ABCC3 mRNA
CTD
PMID:36291160
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
G
Abcg1
ATP binding cassette subfamily G member 1
decreases expression
ISO
tebuconazole results in decreased expression of ABCG1 mRNA
CTD
PMID:30458266
NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
G
Abcg5
ATP binding cassette subfamily G member 5
decreases expression
ISO
tebuconazole results in decreased expression of ABCG5 mRNA
CTD
PMID:30458266 PMID:36291160
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
decreases expression
ISO
tebuconazole results in decreased expression of ABO mRNA
CTD
PMID:30458266
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
G
Acat2
acetyl-Coenzyme A acetyltransferase 2
increases expression
ISO
tebuconazole results in increased expression of ACAT2 mRNA
CTD
PMID:36291160
NCBI chr17:13,161,929...13,179,612
Ensembl chr17:13,161,777...13,179,634
G
Acer2
alkaline ceramidase 2
decreases expression
ISO
tebuconazole results in decreased expression of ACER2 mRNA
CTD
PMID:30458266
NCBI chr 4:86,792,585...86,853,059
Ensembl chr 4:86,792,633...86,853,059
G
Acot11
acyl-CoA thioesterase 11
decreases expression
ISO
tebuconazole results in decreased expression of ACOT11 mRNA
CTD
PMID:30458266
NCBI chr 4:106,601,752...106,662,204
Ensembl chr 4:106,601,752...106,662,195
G
Acox1
acyl-Coenzyme A oxidase 1, palmitoyl
multiple interactions decreases expression
ISO
[propiconazole co-treated with tebuconazole] results in decreased expression of ACOX1 mRNA; [tebuconazole co-treated with fludioxonil] results in decreased expression of ACOX1 mRNA tebuconazole results in decreased expression of ACOX1 mRNA
CTD
PMID:30989312 PMID:33575850
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
G
Acss1
acyl-CoA synthetase short-chain family member 1
decreases expression
ISO
tebuconazole results in decreased expression of ACSS1 mRNA
CTD
PMID:30458266
NCBI chr 2:150,460,031...150,510,160
Ensembl chr 2:150,460,025...150,510,420
G
Actl7a
actin-like 7a
decreases expression
ISO
tebuconazole results in decreased expression of ACTL7A mRNA
CTD
PMID:30458266
NCBI chr 4:56,743,422...56,744,925
Ensembl chr 4:56,743,413...56,744,925
G
Adamts19
ADAM metallopeptidase with thrombospondin type 1 motif 19
decreases expression
ISO
tebuconazole results in decreased expression of ADAMTS19 mRNA
CTD
PMID:30458266
NCBI chr18:58,967,819...59,186,754
Ensembl chr18:58,969,739...59,187,132
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
decreases expression
ISO
tebuconazole results in decreased expression of ADH4 mRNA
CTD
PMID:30458266
NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
G
Ahr
aryl-hydrocarbon receptor
multiple interactions
ISO
AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A1 mRNA]; AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A2 mRNA]
CTD
PMID:30458266
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Akap5
A kinase anchor protein 5
decreases expression
ISO
tebuconazole results in decreased expression of AKAP5 mRNA
CTD
PMID:30458266
NCBI chr12:76,371,652...76,380,925
Ensembl chr12:76,371,665...76,380,927
G
Aknad1
AKNA domain containing 1
decreases expression
ISO
tebuconazole results in decreased expression of AKNAD1 mRNA
CTD
PMID:30458266
NCBI chr 3:108,646,876...108,689,625
Ensembl chr 3:108,646,974...108,689,625
G
Akr1b10
aldo-keto reductase family 1, member B10
multiple interactions increases expression
ISO
[propiconazole co-treated with tebuconazole] results in increased expression of AKR1B10 mRNA tebuconazole results in increased expression of AKR1B10 mRNA
CTD
PMID:30989312
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
G
Aldh1a3
aldehyde dehydrogenase family 1, subfamily A3
decreases expression
ISO
tebuconazole results in decreased expression of ALDH1A3 mRNA
CTD
PMID:30458266
NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265
G
Aldob
aldolase B, fructose-bisphosphate
decreases expression
ISO
tebuconazole results in decreased expression of ALDOB mRNA
CTD
PMID:30458266
NCBI chr 4:49,535,993...49,549,546
Ensembl chr 4:49,535,995...49,549,546
G
Amotl1
angiomotin-like 1
decreases expression
ISO
tebuconazole results in decreased expression of AMOTL1 mRNA
CTD
PMID:30458266
NCBI chr 9:14,453,262...14,574,408
Ensembl chr 9:14,453,262...14,556,352
G
Ankrd61
ankyrin repeat domain 61
decreases expression
ISO
tebuconazole results in decreased expression of ANKRD61 mRNA
CTD
PMID:30458266
NCBI chr 5:143,827,455...143,831,885
Ensembl chr 5:143,827,559...143,834,503
G
Anxa10
annexin A10
increases expression
ISO
tebuconazole results in increased expression of ANXA10 mRNA
CTD
PMID:32194361
NCBI chr 8:62,510,076...62,576,227
Ensembl chr 8:62,510,076...62,576,184
G
Apela
apelin receptor early endogenous ligand
decreases expression
ISO
tebuconazole results in decreased expression of APELA mRNA
CTD
PMID:30458266
NCBI chr 8:65,481,069...65,489,970
Ensembl chr 8:65,481,069...65,489,988
G
Apoa4
apolipoprotein A-IV
decreases expression
ISO
tebuconazole results in decreased expression of APOA4 mRNA
CTD
PMID:30458266
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
Apof
apolipoprotein F
decreases expression
ISO
tebuconazole results in decreased expression of APOF mRNA
CTD
PMID:30458266
NCBI chr10:128,104,568...128,107,119
Ensembl chr10:128,103,866...128,106,022
G
Aqp1
aquaporin 1
increases expression
ISO
tebuconazole results in increased expression of AQP1 mRNA
CTD
PMID:33049508
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
G
Ar
androgen receptor
multiple interactions
ISO
[propiconazole co-treated with prochloraz co-treated with tebuconazole] inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; [tebuconazole co-treated with prochloraz] inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; tebuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tebuconazole inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; tebuconazole inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; tebuconazole inhibits the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:18324785 PMID:21310686 PMID:26602169 PMID:33049310
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Arg1
arginase, liver
decreases expression
ISO
tebuconazole results in decreased expression of ARG1 mRNA
CTD
PMID:32194361
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Atoh8
atonal bHLH transcription factor 8
decreases expression
ISO
tebuconazole results in decreased expression of ATOH8 mRNA
CTD
PMID:30458266
NCBI chr 6:72,183,158...72,212,765
Ensembl chr 6:72,183,161...72,212,561
G
Atp1a2
ATPase, Na+/K+ transporting, alpha 2 polypeptide
increases expression
ISO
tebuconazole results in increased expression of ATP1A2 mRNA
CTD
PMID:28970091
NCBI chr 1:172,099,276...172,125,631
Ensembl chr 1:172,099,276...172,125,631
G
Atp2b3
ATPase, Ca++ transporting, plasma membrane 3
decreases expression
ISO
tebuconazole results in decreased expression of ATP2B3 mRNA
CTD
PMID:30458266
NCBI chr X:72,546,356...72,632,267
Ensembl chr X:72,546,692...72,614,611
G
Atxn7l1
ataxin 7-like 1
decreases expression
ISO
tebuconazole results in decreased expression of ATXN7L1 mRNA
CTD
PMID:30458266
NCBI chr12:33,196,967...33,426,407
Ensembl chr12:33,197,692...33,423,184
G
Basp1
brain abundant, membrane attached signal protein 1
decreases expression
ISO
tebuconazole results in decreased expression of BASP1 mRNA
CTD
PMID:30458266
NCBI chr15:25,363,363...25,413,850
Ensembl chr15:25,363,363...25,413,850
G
Bax
BCL2-associated X protein
increases expression
ISO
tebuconazole results in increased expression of BAX protein
CTD
PMID:26852204 PMID:32735800
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
BC048671
cDNA sequence BC048671
decreases expression
ISO
tebuconazole results in decreased expression of C3ORF22 mRNA
CTD
PMID:30458266
NCBI chr 6:90,278,201...90,282,430
Ensembl chr 6:90,278,201...90,282,431
G
Bcl2
B cell leukemia/lymphoma 2
decreases expression
ISO
tebuconazole results in decreased expression of BCL2 protein
CTD
PMID:26852204 PMID:32735800
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bicra
BRD4 interacting chromatin remodeling complex associated protein
decreases expression
ISO
tebuconazole results in decreased expression of BICRA mRNA
CTD
PMID:30458266
NCBI chr 7:15,704,596...15,785,047
Ensembl chr 7:15,704,597...15,781,846
G
Bpi
bactericidal permeablility increasing protein
decreases expression
ISO
tebuconazole results in decreased expression of BPI mRNA
CTD
PMID:30458266
NCBI chr 2:158,099,983...158,126,453
Ensembl chr 2:158,100,014...158,126,451
G
C9
complement component 9
decreases expression
ISO
tebuconazole results in decreased expression of C9 mRNA
CTD
PMID:30458266
NCBI chr15:6,474,827...6,528,306
Ensembl chr15:6,474,808...6,528,232
G
Cacna1d
calcium channel, voltage-dependent, L type, alpha 1D subunit
decreases expression
ISO
tebuconazole results in decreased expression of CACNA1D mRNA
CTD
PMID:30458266
NCBI chr14:29,761,898...30,213,113
Ensembl chr14:29,761,896...30,213,412
G
Carmn
cardiac mesoderm enhancer-associated non-coding RNA
decreases expression
ISO
tebuconazole results in decreased expression of CARMN mRNA
CTD
PMID:30458266
NCBI chr18:61,778,947...61,798,481
Ensembl chr18:61,782,325...61,799,611
G
Casp3
caspase 3
increases cleavage
ISO
tebuconazole results in increased cleavage of CASP3 protein
CTD
PMID:32735800
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Cat
catalase
increases activity
ISO
tebuconazole results in increased activity of CAT protein
CTD
PMID:29923317 PMID:32735800
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccdc103
coiled-coil domain containing 103
decreases expression
ISO
tebuconazole results in decreased expression of DNAAF19 mRNA
CTD
PMID:30458266
NCBI chr11:102,772,050...102,776,042
Ensembl chr11:102,772,030...102,776,042
G
Ccdc168
coiled-coil domain containing 168
decreases expression
ISO
tebuconazole results in decreased expression of CCDC168 mRNA
CTD
PMID:30458266
NCBI chr 1:44,095,031...44,118,906
Ensembl chr 1:44,095,032...44,118,906
G
Cd28
CD28 antigen
decreases expression
ISO
tebuconazole results in decreased expression of CD28 mRNA
CTD
PMID:30458266
NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
G
Cd34
CD34 antigen
increases expression
ISO
tebuconazole results in increased expression of CD34 mRNA; tebuconazole results in increased expression of CD34 protein
CTD
PMID:33049508
NCBI chr 1:194,621,239...194,643,587
Ensembl chr 1:194,621,127...194,643,587
G
Cd36
CD36 molecule
multiple interactions increases expression decreases expression
ISO
[propiconazole co-treated with tebuconazole] results in decreased expression of CD36 mRNA tebuconazole results in increased expression of CD36 mRNA; tebuconazole results in increased expression of CD36 protein tebuconazole results in decreased expression of CD36 mRNA
CTD
PMID:30989312 PMID:33049508
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cdh23
cadherin related 23 (otocadherin)
decreases expression
ISO
tebuconazole results in decreased expression of CDH23 mRNA
CTD
PMID:30458266
NCBI chr10:60,138,527...60,532,291
Ensembl chr10:60,138,527...60,532,269
G
Cfap276
cilia and flagella associated protein 276
decreases expression
ISO
tebuconazole results in decreased expression of CFAP276 mRNA
CTD
PMID:30458266
NCBI chr 3:108,444,900...108,452,013
Ensembl chr 3:108,441,466...108,452,039
G
Cfap58
cilia and flagella associated protein 58
decreases expression
ISO
tebuconazole results in decreased expression of CFAP58 mRNA
CTD
PMID:30458266
NCBI chr19:47,926,151...48,023,818
Ensembl chr19:47,926,114...48,023,826
G
Cfap61
cilia and flagella associated protein 61
decreases expression
ISO
tebuconazole results in decreased expression of CFAP61 mRNA
CTD
PMID:30458266
NCBI chr 2:145,776,677...146,056,955
Ensembl chr 2:145,776,704...146,056,959
G
Cfap97d1
CFAP97 domain containing 1
decreases expression
ISO
tebuconazole results in decreased expression of CFAP97D1 mRNA
CTD
PMID:30458266
NCBI chr11:101,877,882...101,883,090
Ensembl chr11:101,875,105...101,883,090
G
Cga
glycoprotein hormones, alpha subunit
decreases expression
ISO
tebuconazole results in decreased expression of CGA mRNA
CTD
PMID:26852204
NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370
G
Cgref1
cell growth regulator with EF hand domain 1
decreases expression
ISO
tebuconazole results in decreased expression of CGREF1 mRNA
CTD
PMID:30458266
NCBI chr 5:31,090,487...31,102,771
Ensembl chr 5:31,090,487...31,102,935
G
Chst13
carbohydrate sulfotransferase 13
decreases expression
ISO
tebuconazole results in decreased expression of CHST13 mRNA
CTD
PMID:30458266
NCBI chr 6:90,285,333...90,302,167
Ensembl chr 6:90,285,331...90,302,167
G
Clec2h
C-type lectin domain family 2, member h
decreases expression
ISO
tebuconazole results in decreased expression of CLEC2D mRNA
CTD
PMID:30458266
NCBI chr 6:128,639,348...128,654,337
Ensembl chr 6:128,639,348...128,654,337
G
Cox4i2
cytochrome c oxidase subunit 4I2
decreases expression
ISO
tebuconazole results in decreased expression of COX4I2 mRNA
CTD
PMID:30458266
NCBI chr 2:152,596,093...152,606,957
Ensembl chr 2:152,596,093...152,606,957
G
Crabp1
cellular retinoic acid binding protein I
decreases expression
ISO
tebuconazole results in decreased expression of CRABP1 mRNA
CTD
PMID:30458266
NCBI chr 9:54,672,032...54,680,394
Ensembl chr 9:54,672,032...54,680,394
G
Crhr1
corticotropin releasing hormone receptor 1
decreases expression
ISO
tebuconazole results in decreased expression of CRHR1 mRNA
CTD
PMID:30458266
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
G
Crppa
CDP-L-ribitol pyrophosphorylase A
increases expression
ISO
tebuconazole results in increased expression of CRPPA mRNA
CTD
PMID:30458266
NCBI chr12:36,430,334...36,739,502
Ensembl chr12:36,431,449...36,739,502
G
Cryba2
crystallin, beta A2
decreases expression
ISO
tebuconazole results in decreased expression of CRYBA2 mRNA
CTD
PMID:30458266
NCBI chr 1:74,929,093...74,938,001
Ensembl chr 1:74,929,093...74,932,302
G
Cryga
crystallin, gamma A
decreases expression
ISO
tebuconazole results in decreased expression of CRYGA mRNA
CTD
PMID:30458266
NCBI chr 1:65,139,552...65,142,532
Ensembl chr 1:65,139,548...65,142,532
G
Crygd
crystallin, gamma D
decreases expression
ISO
tebuconazole results in decreased expression of CRYGD mRNA
CTD
PMID:30458266
NCBI chr 1:65,101,001...65,102,598
Ensembl chr 1:65,101,031...65,102,611
G
Csmd2
CUB and Sushi multiple domains 2
decreases expression
ISO
tebuconazole results in decreased expression of CSMD2 mRNA
CTD
PMID:30458266
NCBI chr 4:127,880,310...128,461,459
Ensembl chr 4:127,881,650...128,461,449
G
Cspg4
chondroitin sulfate proteoglycan 4
decreases expression
ISO
tebuconazole results in decreased expression of CSPG4 mRNA
CTD
PMID:30458266
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
G
Ctnna3
catenin alpha 3
decreases expression
ISO
tebuconazole results in decreased expression of CTNNA3 mRNA
CTD
PMID:30458266
NCBI chr10:63,265,877...64,841,174
Ensembl chr10:63,265,877...64,839,446
G
Cyba
cytochrome b-245, alpha polypeptide
increases expression
ISO
tebuconazole results in increased expression of CYBA mRNA
CTD
PMID:30458266
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases activity
ISO
tebuconazole results in decreased activity of CYP19A1 protein
CTD
PMID:12127262
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases activity increases expression multiple interactions
ISO
tebuconazole results in increased activity of CYP1A1 protein tebuconazole results in increased expression of CYP1A1 mRNA; tebuconazole results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tebuconazole results in increased expression of CYP1A1 mRNA]; [propiconazole co-treated with tebuconazole] results in increased expression of CYP1A1 mRNA; [tebuconazole co-treated with fludioxonil] results in increased expression of CYP1A1 mRNA; AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A1 mRNA]; tebuconazole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]
CTD
PMID:19070657 PMID:25233012 PMID:29923317 PMID:30458266 PMID:32194361 PMID:33049508 PMID:33575850 More...
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions increases activity increases expression
EXP ISO
NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] tebuconazole results in increased activity of CYP1A2 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tebuconazole results in increased expression of CYP1A2 mRNA]; [propiconazole co-treated with tebuconazole] results in increased activity of CYP1A2 protein; [propiconazole co-treated with tebuconazole] results in increased expression of CYP1A2 mRNA; [tebuconazole co-treated with fludioxonil] results in increased expression of CYP1A2 mRNA; AHR protein affects the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] tebuconazole results in increased expression of CYP1A2 mRNA; tebuconazole results in increased expression of CYP1A2 protein
CTD
PMID:25656644 PMID:29923317 PMID:30458266 PMID:33575850
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp26a1
cytochrome P450, family 26, subfamily a, polypeptide 1
increases expression
ISO
tebuconazole results in increased expression of CYP26A1 mRNA
CTD
PMID:28970091
NCBI chr19:37,686,186...37,689,984
Ensembl chr19:37,686,246...37,689,984
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
increases expression multiple interactions
EXP ISO
tebuconazole results in increased expression of CYP2B10 mRNA [tebuconazole co-treated with fludioxonil] results in increased expression of CYP2B6 mRNA tebuconazole results in increased expression of CYP2B6 mRNA NR1I3 inhibits the reaction [tebuconazole results in increased expression of CYP2B10 mRNA]
CTD
PMID:25656644 PMID:30458266 PMID:33575850
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2b13
cytochrome P450, family 2, subfamily b, polypeptide 13
increases expression
ISO
tebuconazole results in increased expression of CYP2B2 protein
CTD
PMID:29923317
NCBI chr 7:25,760,813...25,795,622
Ensembl chr 7:25,760,922...25,795,622
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
affects binding
ISO
tebuconazole binds to CYP2C9 protein; tebuconazole binds to CYP2C9 protein alternative form
CTD
PMID:29621561
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression decreases expression
ISO
tebuconazole results in increased expression of CYP2E1 protein tebuconazole results in decreased expression of CYP2E1 mRNA
CTD
PMID:29923317 PMID:30458266
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP2R1 mRNA
CTD
PMID:30458266
NCBI chr 7:114,149,358...114,162,283
Ensembl chr 7:114,148,917...114,162,207
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
increases expression
EXP
tebuconazole results in increased expression of CYP3A11 mRNA
CTD
PMID:25656644
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Cyp46a1
cytochrome P450, family 46, subfamily a, polypeptide 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP46A1 mRNA
CTD
PMID:30458266
NCBI chr12:108,300,568...108,328,497
Ensembl chr12:108,300,640...108,328,493
G
Cyp4a10
cytochrome P450, family 4, subfamily a, polypeptide 10
multiple interactions increases expression
EXP
NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP4A10 mRNA]
CTD
PMID:25656644
NCBI chr 4:115,375,484...115,390,846
Ensembl chr 4:115,375,461...115,390,846
G
Cyp51
cytochrome P450, family 51
decreases activity increases expression
ISO EXP
tebuconazole results in decreased activity of CYP51A1 protein tebuconazole results in increased expression of CYP51 mRNA
CTD
PMID:16989930 PMID:29337257
NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
G
Cyp7a1
cytochrome P450, family 7, subfamily a, polypeptide 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP7A1 mRNA
CTD
PMID:30458266 PMID:32194361 PMID:36291160
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
G
Cyp8b1
cytochrome P450, family 8, subfamily b, polypeptide 1
decreases expression
ISO
tebuconazole results in decreased expression of CYP8B1 mRNA
CTD
PMID:36291160
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
G
Ddr2
discoidin domain receptor family, member 2
decreases expression
ISO
tebuconazole results in decreased expression of DDR2 mRNA
CTD
PMID:30458266
NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
G
Derl3
Der1-like domain family, member 3
decreases expression
ISO
tebuconazole results in decreased expression of DERL3 mRNA
CTD
PMID:30458266
NCBI chr10:75,729,232...75,731,775
Ensembl chr10:75,729,247...75,731,775
G
Dnah12
dynein, axonemal, heavy chain 12
increases expression
ISO
tebuconazole results in increased expression of DNAH12 mRNA
CTD
PMID:30458266
NCBI chr14:26,412,709...26,614,250
Ensembl chr14:26,414,429...26,613,660
G
Dnmt3l
DNA methyltransferase 3-like
decreases expression
ISO
tebuconazole results in decreased expression of DNMT3L mRNA
CTD
PMID:30458266
NCBI chr10:77,878,121...77,899,456
Ensembl chr10:77,877,781...77,899,456
G
Drgx
dorsal root ganglia homeobox
decreases expression
ISO
tebuconazole results in decreased expression of DRGX mRNA
CTD
PMID:30458266
NCBI chr14:32,317,824...32,371,203
Ensembl chr14:32,321,364...32,371,203
G
Dusp2
dual specificity phosphatase 2
decreases expression
ISO
tebuconazole results in decreased expression of DUSP2 mRNA
CTD
PMID:30458266
NCBI chr 2:127,178,079...127,180,297
Ensembl chr 2:127,178,079...127,180,296
G
Duxbl1
double homeobox B-like 1
decreases expression
ISO
tebuconazole results in decreased expression of DUX4 mRNA
CTD
PMID:30458266
NCBI chr14:25,979,011...25,990,590
Ensembl chr14:25,979,001...25,990,512
G
Egflam
EGF-like, fibronectin type III and laminin G domains
decreases expression
ISO
tebuconazole results in decreased expression of EGFLAM mRNA
CTD
PMID:30458266
NCBI chr15:7,235,598...7,428,203
Ensembl chr15:7,235,601...7,427,876
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases expression
ISO
tebuconazole results in decreased expression of EIF2AK2 mRNA; tebuconazole results in decreased expression of EIF2AK2 protein
CTD
PMID:33049508
NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
tebuconazole binds to and results in increased activity of ESR1 protein
CTD
PMID:33049310
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esrra
estrogen related receptor, alpha
increases expression
ISO
tebuconazole results in increased expression of ESRRA mRNA; tebuconazole results in increased expression of ESRRA protein
CTD
PMID:33049508
NCBI chr19:6,888,345...6,899,182
Ensembl chr19:6,888,345...6,899,208
G
F13a1
coagulation factor XIII, A1 subunit
decreases expression
ISO
tebuconazole results in decreased expression of F13A1 mRNA
CTD
PMID:30458266
NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220
G
Fam181a
family with sequence similarity 181, member A
decreases expression
ISO
tebuconazole results in decreased expression of FAM181A mRNA
CTD
PMID:30458266
NCBI chr12:103,277,272...103,283,326
Ensembl chr12:103,277,234...103,283,324
G
Fam187b
family with sequence similarity 187, member B
decreases expression
ISO
tebuconazole results in decreased expression of FAM187B mRNA
CTD
PMID:30458266
NCBI chr 7:30,673,219...30,689,151
Ensembl chr 7:30,673,215...30,689,151
G
Fasn
fatty acid synthase
increases expression multiple interactions
ISO
tebuconazole results in increased expression of FASN mRNA [propiconazole co-treated with tebuconazole] results in increased expression of FASN mRNA
CTD
PMID:30989312
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
G
Fcer1a
Fc receptor, IgE, high affinity I, alpha polypeptide
decreases expression
ISO
tebuconazole results in decreased expression of FCER1A mRNA
CTD
PMID:30458266
NCBI chr 1:173,048,836...173,054,799
Ensembl chr 1:173,048,851...173,054,781
G
Fgf5
fibroblast growth factor 5
decreases expression
ISO
tebuconazole results in decreased expression of FGF5 mRNA
CTD
PMID:30458266
NCBI chr 5:98,402,108...98,424,892
Ensembl chr 5:98,402,043...98,424,889
G
Fgfbp3
fibroblast growth factor binding protein 3
increases expression
ISO
tebuconazole results in increased expression of FGFBP3 mRNA
CTD
PMID:28970091
NCBI chr19:36,894,950...36,896,999
Ensembl chr19:36,894,950...36,897,015
G
Flna
filamin, alpha
decreases expression
ISO
tebuconazole results in decreased expression of FLNA mRNA
CTD
PMID:30458266
NCBI chr X:73,267,067...73,293,787
Ensembl chr X:73,267,067...73,293,426
G
Folr2
folate receptor beta
decreases expression
ISO
tebuconazole results in decreased expression of FOLR2 mRNA
CTD
PMID:30458266
NCBI chr 7:101,489,195...101,506,397
Ensembl chr 7:101,489,195...101,506,401
G
Frmpd2
FERM and PDZ domain containing 2
decreases expression
ISO
tebuconazole results in decreased expression of FRMPD2 mRNA
CTD
PMID:30458266
NCBI chr14:33,193,475...33,297,226
Ensembl chr14:33,193,653...33,297,226
G
Fscn1
fascin actin-bundling protein 1
decreases expression
ISO
tebuconazole results in decreased expression of FSCN1 mRNA
CTD
PMID:30458266
NCBI chr 5:142,946,110...142,958,944
Ensembl chr 5:142,946,098...142,958,940
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
tebuconazole results in decreased expression of G6PC1 mRNA
CTD
PMID:30458266 PMID:32194361
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
G
Gabrp
gamma-aminobutyric acid type A receptor subunit pi
decreases expression
ISO
tebuconazole results in decreased expression of GABRP mRNA
CTD
PMID:30458266
NCBI chr11:33,500,781...33,528,978
Ensembl chr11:33,500,781...33,528,959
G
Gadd45b
growth arrest and DNA-damage-inducible 45 beta
increases expression
EXP
tebuconazole results in increased expression of GADD45B mRNA
CTD
PMID:25656644
NCBI chr10:80,765,925...80,768,038
Ensembl chr10:80,765,907...80,768,038
G
Gfm1
G elongation factor, mitochondrial 1
increases expression
ISO
tebuconazole results in increased expression of GFM1 mRNA
CTD
PMID:30458266
NCBI chr 3:67,337,448...67,382,401
Ensembl chr 3:67,337,429...67,383,862
G
Ghrhr
growth hormone releasing hormone receptor
decreases expression
ISO
tebuconazole results in decreased expression of GHRHR mRNA
CTD
PMID:30458266
NCBI chr 6:55,353,204...55,365,515
Ensembl chr 6:55,353,280...55,365,515
G
Gm17266
predicted gene, 17266
increases expression
ISO
tebuconazole results in increased expression of C18ORF63 mRNA
CTD
PMID:30458266
NCBI chr18:84,813,104...84,856,766
Ensembl chr18:84,816,683...84,854,841
G
Gm38812
predicted gene, 38812
decreases expression
ISO
tebuconazole results in decreased expression of HOXA10-AS mRNA
CTD
PMID:30458266
G
Gm40318
predicted gene, 40318
increases expression
ISO
tebuconazole results in increased expression of S100P protein
CTD
PMID:32194361
NCBI chr 5:36,919,848...36,924,763
Ensembl chr 5:36,919,961...36,924,039
G
Gm49817
predicted gene, 49817
decreases expression
ISO
tebuconazole results in decreased expression of PLEKHG7 mRNA
CTD
PMID:30458266
NCBI chr10:95,888,057...95,962,580
G
Gnmt
glycine N-methyltransferase
decreases expression
ISO
tebuconazole results in decreased expression of GNMT mRNA
CTD
PMID:30458266
NCBI chr17:47,036,590...47,040,091
Ensembl chr17:47,036,590...47,040,094
G
Gp9
glycoprotein 9 platelet
decreases expression
ISO
tebuconazole results in decreased expression of GP9 mRNA
CTD
PMID:30458266
NCBI chr 6:87,753,115...87,756,768
Ensembl chr 6:87,755,054...87,756,750
G
Gpat2
glycerol-3-phosphate acyltransferase 2, mitochondrial
decreases expression
ISO
tebuconazole results in decreased expression of GPAT2 mRNA
CTD
PMID:30458266
NCBI chr 2:127,266,725...127,278,013
Ensembl chr 2:127,267,119...127,278,012
G
Gpd1
glycerol-3-phosphate dehydrogenase 1 (soluble)
increases expression multiple interactions
ISO
tebuconazole results in increased expression of GPD1 mRNA [propiconazole co-treated with tebuconazole] results in increased expression of GPD1 mRNA
CTD
PMID:30989312
NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886
G
Gsr
glutathione reductase
decreases activity
ISO
tebuconazole results in decreased activity of GSR protein
CTD
PMID:32735800
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstm2
glutathione S-transferase, mu 2
increases expression
ISO
tebuconazole results in increased expression of GSTM2 mRNA
CTD
PMID:30458266
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
G
Guca1b
guanylate cyclase activator 1B
decreases expression
ISO
tebuconazole results in decreased expression of GUCA1B mRNA
CTD
PMID:30458266
NCBI chr17:47,692,526...47,703,892
Ensembl chr17:47,696,318...47,703,892
G
H1f9
H1.9 linker histone
decreases expression
ISO
tebuconazole results in decreased expression of H1-9P mRNA
CTD
PMID:30458266
NCBI chr11:94,858,419...94,859,282
Ensembl chr11:94,858,419...94,859,282
G
Hamp
hepcidin antimicrobial peptide
decreases expression
ISO
tebuconazole results in decreased expression of HAMP mRNA
CTD
PMID:33049508
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
ISO
tebuconazole results in decreased expression of HBA2 mRNA
CTD
PMID:30458266
NCBI chr11:32,246,492...32,247,310
Ensembl chr11:32,246,489...32,247,298
G
Hbb-bh1
hemoglobin Z, beta-like embryonic chain
decreases expression
ISO
tebuconazole results in decreased expression of HBG1 mRNA
CTD
PMID:30458266
NCBI chr 7:103,490,845...103,492,369
Ensembl chr 7:103,490,844...103,492,371
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
ISO
tebuconazole results in decreased expression of HBEGF mRNA
CTD
PMID:26852204
NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
G
Hbq1b
hemoglobin, theta 1B
decreases expression
ISO
tebuconazole results in decreased expression of HBQ1 mRNA
CTD
PMID:30458266
NCBI chr11:32,236,964...32,237,912
Ensembl chr11:32,236,965...32,237,784
G
Hdc
histidine decarboxylase
decreases expression
ISO
tebuconazole results in decreased expression of HDC mRNA
CTD
PMID:30458266
NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219
G
Heph
hephaestin
decreases expression
ISO
tebuconazole results in decreased expression of HEPH mRNA
CTD
PMID:30458266
NCBI chr X:95,499,042...95,618,091
Ensembl chr X:95,498,965...95,618,091
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
increases expression
ISO
tebuconazole results in increased expression of HMGCR mRNA
CTD
PMID:30458266 PMID:36291160
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmgcs1
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
increases expression
ISO
tebuconazole results in increased expression of HMGCS1 mRNA
CTD
PMID:36291160
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
G
Hmgcs2
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2
decreases expression
ISO
tebuconazole results in decreased expression of HMGCS2 mRNA
CTD
PMID:30458266
NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
G
Hmx1
H6 homeobox 1
decreases expression
ISO
tebuconazole results in decreased expression of HMX1 mRNA
CTD
PMID:30458266
NCBI chr 5:35,546,124...35,557,629
Ensembl chr 5:35,546,452...35,557,074
G
Homer2
homer scaffolding protein 2
decreases expression
ISO
tebuconazole results in decreased expression of HOMER2 mRNA
CTD
PMID:30458266
NCBI chr 7:81,250,229...81,356,673
Ensembl chr 7:81,250,229...81,357,275
G
Hsd17b7
hydroxysteroid (17-beta) dehydrogenase 7
increases expression
ISO
tebuconazole results in increased expression of HSD17B7 mRNA
CTD
PMID:30458266
NCBI chr 1:169,777,109...169,796,757
Ensembl chr 1:169,777,104...169,796,810
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
decreases expression
ISO
tebuconazole results in decreased expression of HTR2A mRNA
CTD
PMID:30458266
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Igsf3
immunoglobulin superfamily, member 3
decreases expression
ISO
tebuconazole results in decreased expression of IGSF3 mRNA
CTD
PMID:30458266
NCBI chr 3:101,284,306...101,370,375
Ensembl chr 3:101,284,399...101,370,375
G
Inhbe
inhibin beta-E
decreases expression
ISO
tebuconazole results in decreased expression of INHBE mRNA
CTD
PMID:30458266
NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
G
Insig1
insulin induced gene 1
increases expression multiple interactions
ISO
tebuconazole results in increased expression of INSIG1 mRNA [propiconazole co-treated with tebuconazole] results in increased expression of INSIG1 mRNA
CTD
PMID:30458266 PMID:30989312
NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660
G
Irf6
interferon regulatory factor 6
decreases expression
ISO
tebuconazole results in decreased expression of IRF6 mRNA
CTD
PMID:30458266
NCBI chr 1:192,835,420...192,854,344
Ensembl chr 1:192,835,419...192,854,331
G
Islr2
immunoglobulin superfamily containing leucine-rich repeat 2
decreases expression
ISO
tebuconazole results in decreased expression of ISLR2 mRNA
CTD
PMID:30458266
NCBI chr 9:58,103,580...58,113,563
Ensembl chr 9:58,103,580...58,111,602
G
Itgad
integrin, alpha D
decreases expression
ISO
tebuconazole results in decreased expression of ITGAD mRNA
CTD
PMID:30458266
NCBI chr 7:127,773,105...127,822,988
Ensembl chr 7:127,753,548...127,822,988
G
Jag1
jagged 1
increases expression
ISO
tebuconazole results in increased expression of JAG1 mRNA; tebuconazole results in increased expression of JAG1 protein
CTD
PMID:33049508
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
G
Jag2
jagged 2
decreases expression
ISO
tebuconazole results in decreased expression of JAG2 mRNA
CTD
PMID:30458266
NCBI chr12:112,871,439...112,893,437
Ensembl chr12:112,871,439...112,893,396
G
Kcnk7
potassium channel, subfamily K, member 7
decreases expression
ISO
tebuconazole results in decreased expression of KCNK7 mRNA
CTD
PMID:30458266
NCBI chr19:5,754,471...5,757,956
Ensembl chr19:5,754,395...5,757,137
G
Kdm2b
lysine (K)-specific demethylase 2B
decreases expression
ISO
tebuconazole results in decreased expression of KDM2B mRNA
CTD
PMID:30458266
NCBI chr 5:123,008,727...123,127,333
Ensembl chr 5:123,008,728...123,127,886
G
Kif17
kinesin family member 17
decreases expression
ISO
tebuconazole results in decreased expression of KIF17 mRNA
CTD
PMID:30458266
NCBI chr 4:137,989,562...138,029,284
Ensembl chr 4:137,977,746...138,029,278
G
Kif5a
kinesin family member 5A
decreases expression
ISO
tebuconazole results in decreased expression of KIF5A mRNA
CTD
PMID:30458266
NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217
G
Kiz
kizuna centrosomal protein
decreases expression
ISO
tebuconazole results in decreased expression of KIZ mRNA
CTD
PMID:30458266
NCBI chr 2:146,697,743...146,812,018
Ensembl chr 2:146,697,784...146,812,017
G
Krtap3-1
keratin associated protein 3-1
decreases expression
ISO
tebuconazole results in decreased expression of KRTAP3-1 mRNA
CTD
PMID:30458266
NCBI chr11:99,456,853...99,457,456
Ensembl chr11:99,456,853...99,457,456
G
Lbh
limb-bud and heart
decreases expression
ISO
tebuconazole results in decreased expression of LBH mRNA
CTD
PMID:30458266
NCBI chr17:73,225,300...73,248,941
Ensembl chr17:73,225,300...73,248,942
G
Lcn3
lipocalin 3
decreases expression
ISO
tebuconazole results in decreased expression of LCN1 mRNA
CTD
PMID:30458266
NCBI chr 2:25,655,545...25,658,110
Ensembl chr 2:25,655,581...25,658,111
G
Lctl
lactase-like
decreases expression
ISO
tebuconazole results in decreased expression of LCTL mRNA
CTD
PMID:30458266
NCBI chr 9:64,024,399...64,045,400
Ensembl chr 9:64,024,429...64,045,400
G
Lhx1
LIM homeobox protein 1
increases expression
ISO
tebuconazole results in increased expression of LHX1 mRNA
CTD
PMID:28970091
NCBI chr11:84,408,801...84,416,360
Ensembl chr11:84,409,110...84,416,361
G
Lilrb4b
leukocyte immunoglobulin-like receptor, subfamily B, member 4B
decreases expression
ISO
tebuconazole results in decreased expression of LILRB4 mRNA
CTD
PMID:30458266
NCBI chr10:51,356,757...51,362,417
Ensembl chr10:51,356,728...51,362,799
G
Lrrc31
leucine rich repeat containing 31
decreases expression
ISO
tebuconazole results in decreased expression of LRRC31 mRNA
CTD
PMID:30458266
NCBI chr 3:30,732,703...30,753,992
Ensembl chr 3:30,732,703...30,753,992
G
Lrrc75a
leucine rich repeat containing 75A
increases expression
ISO
tebuconazole results in increased expression of LRRC75A mRNA
CTD
PMID:28970091
NCBI chr11:62,495,708...62,539,411
Ensembl chr11:62,495,710...62,539,349
G
Lss
lanosterol synthase
increases expression
ISO
tebuconazole results in increased expression of LSS mRNA
CTD
PMID:30458266 PMID:36291160
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
G
Mab21l3
mab-21-like 3
decreases expression
ISO
tebuconazole results in decreased expression of MAB21L3 mRNA
CTD
PMID:30458266
NCBI chr 3:101,720,392...101,743,601
Ensembl chr 3:101,720,392...101,756,275
G
Mab21l4
mab-21-like 4
decreases expression
ISO
tebuconazole results in decreased expression of MAB21L4 mRNA
CTD
PMID:30458266
NCBI chr 1:93,079,076...93,088,679
Ensembl chr 1:93,079,071...93,088,670
G
Matn1
matrilin 1, cartilage matrix protein
decreases expression
ISO
tebuconazole results in decreased expression of MATN1 mRNA
CTD
PMID:30458266
NCBI chr 4:130,671,696...130,682,787
Ensembl chr 4:130,671,696...130,682,786
G
Mcf2l
mcf.2 transforming sequence-like
decreases expression
ISO
tebuconazole results in decreased expression of MCF2L mRNA
CTD
PMID:30458266
NCBI chr 8:12,923,806...13,070,502
Ensembl chr 8:12,923,806...13,070,905
G
Meg3
maternally expressed 3
decreases expression
ISO
tebuconazole results in decreased expression of MEG3 mRNA
CTD
PMID:30458266
NCBI chr12:109,506,879...109,538,163
Ensembl chr12:109,506,877...109,538,165
G
Mfap5
microfibrillar associated protein 5
decreases expression
ISO
tebuconazole results in decreased expression of MFAP5 mRNA
CTD
PMID:30458266
NCBI chr 6:122,490,543...122,506,249
Ensembl chr 6:122,482,804...122,506,249
G
Miox
myo-inositol oxygenase
decreases expression
ISO
tebuconazole results in decreased expression of MIOX mRNA
CTD
PMID:30458266
NCBI chr15:89,218,676...89,221,210
Ensembl chr15:89,218,601...89,221,218
G
Mlxipl
MLX interacting protein-like
multiple interactions increases expression
ISO
[propiconazole co-treated with tebuconazole] results in increased expression of MLXIPL mRNA; [tebuconazole co-treated with fludioxonil] results in decreased expression of MLXIPL mRNA tebuconazole results in increased expression of MLXIPL mRNA
CTD
PMID:30989312 PMID:33575850
NCBI chr 5:135,118,744...135,168,622
Ensembl chr 5:135,118,744...135,167,236
G
Mmp2
matrix metallopeptidase 2
decreases expression
ISO
tebuconazole results in decreased expression of MMP2 mRNA
CTD
PMID:26852204
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp21
matrix metallopeptidase 21
decreases expression
ISO
tebuconazole results in decreased expression of MMP21 mRNA
CTD
PMID:30458266
NCBI chr 7:133,275,999...133,281,790
Ensembl chr 7:133,275,999...133,281,790
G
Mmp9
matrix metallopeptidase 9
decreases expression
ISO
tebuconazole results in decreased expression of MMP9 mRNA
CTD
PMID:26852204
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mrgpre
MAS-related GPR, member E
decreases expression
ISO
tebuconazole results in decreased expression of MRGPRE mRNA
CTD
PMID:30458266
NCBI chr 7:143,332,100...143,338,237
Ensembl chr 7:143,332,100...143,338,237
G
Mro
maestro
decreases expression
ISO
tebuconazole results in decreased expression of MRO mRNA
CTD
PMID:30458266
NCBI chr18:73,992,465...74,014,405
Ensembl chr18:73,992,456...74,014,404
G
Msmo1
methylsterol monoxygenase 1
increases expression
ISO EXP
tebuconazole results in increased expression of MSMO1 mRNA
CTD
PMID:28970091 PMID:29337257 PMID:36291160
NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
G
Msx2
msh homeobox 2
decreases expression
ISO
tebuconazole results in decreased expression of MSX2 mRNA
CTD
PMID:30458266
NCBI chr13:53,620,917...53,626,816
Ensembl chr13:53,620,920...53,627,110
G
Muc3a
mucin 3A, cell surface associated
decreases expression
ISO
tebuconazole results in decreased expression of MUC3A mRNA
CTD
PMID:30458266
NCBI chr 5:137,243,263...137,276,564
Ensembl chr 5:137,243,270...137,246,852
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
decreases expression
ISO
tebuconazole results in decreased expression of MUC5AC mRNA
CTD
PMID:30458266
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Mvd
mevalonate (diphospho) decarboxylase
increases expression
ISO
tebuconazole results in increased expression of MVD mRNA
CTD
PMID:30458266
NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161
G
Myog
myogenin
decreases expression
ISO
tebuconazole results in decreased expression of MYOG mRNA
CTD
PMID:30458266
NCBI chr 1:134,217,742...134,220,286
Ensembl chr 1:134,217,727...134,220,286
G
Myrfl
myelin regulatory factor-like
decreases expression
ISO
tebuconazole results in decreased expression of MYRFL mRNA
CTD
PMID:30458266
NCBI chr10:116,612,450...116,732,784
Ensembl chr10:116,612,440...116,732,824
G
Ndnf
neuron-derived neurotrophic factor
increases expression
ISO
tebuconazole results in increased expression of NDNF mRNA
CTD
PMID:28970091
NCBI chr 6:65,648,595...65,689,307
Ensembl chr 6:65,648,574...65,689,310
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
increases expression
ISO
tebuconazole results in increased expression of NGFR mRNA
CTD
PMID:28970091
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
Niban1
niban apoptosis regulator 1
decreases expression
ISO
tebuconazole results in decreased expression of NIBAN1 mRNA
CTD
PMID:30458266
NCBI chr 1:151,447,215...151,597,690
Ensembl chr 1:151,446,937...151,597,690
G
Nid2
nidogen 2
decreases expression
ISO
tebuconazole results in decreased expression of NID2 mRNA
CTD
PMID:30458266
NCBI chr14:19,801,325...19,861,855
Ensembl chr14:19,801,333...19,861,855
G
Nphs2
nephrosis 2, podocin
decreases expression
ISO
tebuconazole results in decreased expression of NPHS2 mRNA
CTD
PMID:30458266
NCBI chr 1:156,138,105...156,155,605
Ensembl chr 1:156,138,297...156,155,605
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity multiple interactions
ISO EXP
tebuconazole results in increased activity of NR1I2 protein tebuconazole binds to and results in increased activity of NR1I2 protein [tebuconazole results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA; tebuconazole binds to and results in increased activity of NR1I2 protein
CTD
PMID:28728110 PMID:29420809 PMID:33049310 PMID:36291160
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
affects response to substance decreases activity decreases expression multiple interactions increases response to substance
EXP ISO
NR1I3 protein affects the susceptibility to tebuconazole tebuconazole results in decreased activity of NR1I3 protein tebuconazole results in decreased expression of NR1I3 mRNA [tebuconazole co-treated with fludioxonil] results in decreased expression of NR1I3 mRNA; tebuconazole binds to and results in decreased activity of NR1I3 protein NR1I3 results in increased susceptibility to tebuconazole NR1I3 inhibits the reaction [tebuconazole results in increased expression of CYP2B10 mRNA]; NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP1A2 mRNA]; NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP4A10 mRNA]; NR1I3 promotes the reaction [tebuconazole results in increased expression of POR mRNA]
CTD
PMID:23721867 PMID:25656644 PMID:29420809 PMID:33575850 PMID:36291160
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
G
Nutm1
NUT midline carcinoma, family member 1
increases expression
ISO
tebuconazole results in increased expression of NUTM1 mRNA
CTD
PMID:30458266
NCBI chr 2:112,078,293...112,089,636
Ensembl chr 2:112,078,293...112,089,636
G
Obscn
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
decreases expression
ISO
tebuconazole results in decreased expression of OBSCN mRNA
CTD
PMID:30458266
NCBI chr11:58,885,082...59,027,201
Ensembl chr11:58,885,082...59,029,996
G
Odf4
outer dense fiber of sperm tails 4
decreases expression
ISO
tebuconazole results in decreased expression of ODF4 mRNA
CTD
PMID:30458266
NCBI chr11:68,812,661...68,817,907
Ensembl chr11:68,812,661...68,817,907
G
Oprl1
opioid receptor-like 1
decreases expression
ISO
tebuconazole results in decreased expression of OPRL1 mRNA
CTD
PMID:30458266
NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778
G
Or10c1
olfactory receptor family 10 subfamily C member 1
decreases expression
ISO
tebuconazole results in decreased expression of OR10C1 mRNA
CTD
PMID:30458266
NCBI chr17:37,521,804...37,522,742
Ensembl chr17:37,518,841...37,524,009
G
Or2t1
olfactory receptor family 2 subfamily T member 1
decreases expression
ISO
tebuconazole results in decreased expression of OR2T1 mRNA
CTD
PMID:30458266
NCBI chr14:8,140,697...8,141,650
Ensembl chr14:8,137,972...8,146,935
G
Or4d10b
olfactory receptor family 4 subfamily D member 10B
decreases expression
ISO
tebuconazole results in decreased expression of OR4D10 mRNA
CTD
PMID:30458266
NCBI chr19:12,036,173...12,037,114
Ensembl chr19:12,035,988...12,040,046
G
Pabpn1l
poly(A)binding protein nuclear 1-like
decreases expression
ISO
tebuconazole results in decreased expression of PABPN1L mRNA
CTD
PMID:30458266
NCBI chr 8:123,346,210...123,349,474
Ensembl chr 8:123,346,210...123,349,478
G
Pak1
p21 (RAC1) activated kinase 1
decreases expression
ISO
tebuconazole results in decreased expression of PAK1 mRNA
CTD
PMID:30458266
NCBI chr 7:97,437,748...97,561,588
Ensembl chr 7:97,437,748...97,561,588
G
Palld
palladin, cytoskeletal associated protein
decreases expression
ISO
tebuconazole results in decreased expression of PALLD mRNA
CTD
PMID:30458266
NCBI chr 8:61,964,465...62,355,741
Ensembl chr 8:61,964,467...62,355,724
G
Panx3
pannexin 3
decreases expression
ISO
tebuconazole results in decreased expression of PANX3 mRNA
CTD
PMID:30458266
NCBI chr 9:37,571,198...37,580,518
Ensembl chr 9:37,571,198...37,580,531
G
Pgf
placental growth factor
decreases expression
ISO
tebuconazole results in decreased expression of PGF mRNA
CTD
PMID:26852204
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Plau
plasminogen activator, urokinase
decreases expression
ISO
tebuconazole results in decreased expression of PLAU mRNA
CTD
PMID:26852204
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pln
phospholamban
increases expression
ISO
tebuconazole results in increased expression of PLN mRNA
CTD
PMID:33049508
NCBI chr10:53,213,782...53,222,095
Ensembl chr10:53,213,763...53,222,083
G
Pnliprp1
pancreatic lipase related protein 1
decreases expression
ISO
tebuconazole results in decreased expression of PNLIPRP1 mRNA
CTD
PMID:30458266
NCBI chr19:58,717,319...58,732,601
Ensembl chr19:58,717,319...58,732,601
G
Por
cytochrome p450 oxidoreductase
increases expression multiple interactions
EXP
tebuconazole results in increased expression of POR mRNA NR1I3 promotes the reaction [tebuconazole results in increased expression of POR mRNA]
CTD
PMID:25656644
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
ISO EXP
tebuconazole binds to and results in increased activity of PPARG protein
CTD
PMID:33049310
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Prg2
proteoglycan 2, bone marrow
decreases expression
ISO
tebuconazole results in decreased expression of PRG2 mRNA
CTD
PMID:30458266
NCBI chr 2:84,810,805...84,813,977
Ensembl chr 2:84,810,805...84,813,976
G
Prkaa1
protein kinase, AMP-activated, alpha 1 catalytic subunit
multiple interactions
EXP
[tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA1 protein
CTD
PMID:30698772
NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
G
Prkaa2
protein kinase, AMP-activated, alpha 2 catalytic subunit
multiple interactions
EXP
[tebuconazole co-treated with Econazole] results in increased phosphorylation of PRKAA2 protein
CTD
PMID:30698772
NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[tebuconazole binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2
CTD
PMID:26359731
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptprc
protein tyrosine phosphatase receptor type C
increases expression
ISO
tebuconazole results in increased expression of PTPRC mRNA
CTD
PMID:30458266
NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446
G
Purg
purine-rich element binding protein G
decreases expression
ISO
tebuconazole results in decreased expression of PURG mRNA
CTD
PMID:30458266
NCBI chr 8:33,875,650...33,907,500
Ensembl chr 8:33,876,353...33,907,495
G
Rai1
retinoic acid induced 1
decreases expression
ISO
tebuconazole results in decreased expression of RAI1 mRNA
CTD
PMID:30458266
NCBI chr11:59,995,743...60,090,023
Ensembl chr11:59,995,839...60,090,023
G
Rasal2
RAS protein activator like 2
decreases expression
ISO
tebuconazole results in decreased expression of RASAL2 mRNA
CTD
PMID:30458266
NCBI chr 1:156,962,759...157,240,170
Ensembl chr 1:156,962,752...157,240,165
G
Rasd1
RAS, dexamethasone-induced 1
increases expression
ISO
tebuconazole results in increased expression of RASD1 mRNA
CTD
PMID:28970091
NCBI chr11:59,854,007...59,855,770
Ensembl chr11:59,854,007...59,855,770
G
Ret
ret proto-oncogene
decreases expression
ISO
tebuconazole results in decreased expression of RET mRNA
CTD
PMID:30458266
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Rnd1
Rho family GTPase 1
decreases expression
ISO
tebuconazole results in decreased expression of RND1 mRNA
CTD
PMID:30458266
NCBI chr15:98,567,086...98,575,342
Ensembl chr15:98,561,302...98,575,342
G
Rnf112
ring finger protein 112
increases expression
ISO
tebuconazole results in increased expression of RNF112 mRNA
CTD
PMID:30458266
NCBI chr11:61,339,243...61,345,014
Ensembl chr11:61,339,268...61,344,957
G
Rpp25
ribonuclease P/MRP 25 subunit
decreases expression
ISO
tebuconazole results in decreased expression of RPP25 mRNA
CTD
PMID:30458266
NCBI chr 9:57,411,385...57,412,730
Ensembl chr 9:57,411,309...57,412,731
G
Rps6kl1
ribosomal protein S6 kinase-like 1
decreases expression
ISO
tebuconazole results in decreased expression of RPS6KL1 mRNA
CTD
PMID:30458266
NCBI chr12:85,182,023...85,198,052
Ensembl chr12:85,182,023...85,198,038
G
Rtp3
receptor transporter protein 3
decreases expression
ISO
tebuconazole results in decreased expression of RTP3 mRNA
CTD
PMID:30458266
NCBI chr 9:110,814,003...110,818,781
Ensembl chr 9:110,814,003...110,819,651
G
Runx2
runt related transcription factor 2
decreases expression
ISO
tebuconazole results in decreased expression of RUNX2 mRNA
CTD
PMID:30458266
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
G
Sc5d
sterol-C5-desaturase
increases expression
ISO
tebuconazole results in increased expression of SC5D mRNA
CTD
PMID:28970091
NCBI chr 9:42,162,888...42,175,607
Ensembl chr 9:42,162,891...42,175,552
G
Scn4b
sodium channel, type IV, beta
decreases expression
ISO
tebuconazole results in decreased expression of SCN4B mRNA
CTD
PMID:30458266
NCBI chr 9:45,049,922...45,065,453
Ensembl chr 9:45,049,693...45,065,450
G
Scube1
signal peptide, CUB domain, EGF-like 1
increases expression
ISO
tebuconazole results in increased expression of SCUBE1 mRNA
CTD
PMID:28970091
NCBI chr15:83,486,784...83,609,252
Ensembl chr15:83,489,200...83,609,222
G
Sec14l3
SEC14-like lipid binding 3
decreases expression
ISO
tebuconazole results in decreased expression of SEC14L3 mRNA
CTD
PMID:30458266
NCBI chr11:4,014,853...4,028,990
Ensembl chr11:4,014,841...4,027,736
G
Sele
selectin, endothelial cell
decreases expression
ISO
tebuconazole results in decreased expression of SELE mRNA
CTD
PMID:30458266
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
G
Serpine2
serine (or cysteine) peptidase inhibitor, clade E, member 2
increases expression
ISO
tebuconazole results in increased expression of SERPINE2 mRNA
CTD
PMID:26852204
NCBI chr 1:79,772,038...79,836,382
Ensembl chr 1:79,771,914...79,838,897
G
Sh2d2a
SH2 domain containing 2A
decreases expression
ISO
tebuconazole results in decreased expression of SH2D2A mRNA
CTD
PMID:30458266
NCBI chr 3:87,754,070...87,763,116
Ensembl chr 3:87,754,062...87,763,029
G
Sla
src-like adaptor
increases expression
ISO
tebuconazole results in increased expression of SLA mRNA
CTD
PMID:30458266
NCBI chr15:66,652,713...66,703,921
Ensembl chr15:66,652,668...66,703,678
G
Slc10a1
solute carrier family 10 (sodium/bile acid cotransporter family), member 1
decreases expression
ISO
tebuconazole results in decreased expression of SLC10A1 mRNA
CTD
PMID:36291160
NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
G
Slc16a11
solute carrier family 16 (monocarboxylic acid transporters), member 11
decreases expression
ISO
tebuconazole results in decreased expression of SLC16A11 mRNA
CTD
PMID:30458266
NCBI chr11:70,104,717...70,107,239
Ensembl chr11:70,103,578...70,107,243
G
Slc22a15
solute carrier family 22 (organic anion/cation transporter), member 15
increases expression
ISO
tebuconazole results in increased expression of SLC22A15 mRNA
CTD
PMID:30458266
NCBI chr 3:101,763,084...101,831,769
Ensembl chr 3:101,763,092...101,831,769
G
Slc22a7
solute carrier family 22 (organic anion transporter), member 7
decreases expression
ISO
tebuconazole results in decreased expression of SLC22A7 mRNA
CTD
PMID:30458266
NCBI chr17:46,743,111...46,749,403
Ensembl chr17:46,743,109...46,749,383
G
Slc22a8
solute carrier family 22 (organic anion transporter), member 8
decreases activity
ISO
tebuconazole results in decreased activity of SLC22A8 protein
CTD
PMID:36669674
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
G
Slc4a1
solute carrier family 4 (anion exchanger), member 1
decreases expression
ISO
tebuconazole results in decreased expression of SLC4A1 mRNA
CTD
PMID:30458266
NCBI chr11:102,239,646...102,256,107
Ensembl chr11:102,239,650...102,257,029
G
Slc51a
solute carrier family 51, alpha subunit
decreases expression
ISO
tebuconazole results in decreased expression of SLC51A mRNA
CTD
PMID:36291160
NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
G
Slc5a5
solute carrier family 5 (sodium iodide symporter), member 5
decreases expression
ISO
tebuconazole results in decreased expression of SLC5A5 mRNA
CTD
PMID:30458266
NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
G
Slc6a5
solute carrier family 6 (neurotransmitter transporter, glycine), member 5
decreases expression
ISO
tebuconazole results in decreased expression of SLC6A5 mRNA
CTD
PMID:30458266
NCBI chr 7:49,556,733...49,613,612
Ensembl chr 7:49,559,894...49,613,604
G
Slc9a1
solute carrier family 9 (sodium/hydrogen exchanger), member 1
decreases expression
ISO
tebuconazole results in decreased expression of SLC9A1 mRNA
CTD
PMID:30458266
NCBI chr 4:133,097,022...133,151,013
Ensembl chr 4:133,097,017...133,151,013
G
Slit1
slit guidance ligand 1
decreases expression
ISO
tebuconazole results in decreased expression of SLIT1 mRNA
CTD
PMID:30458266
NCBI chr19:41,586,263...41,735,714
Ensembl chr19:41,588,696...41,732,104
G
Smco1
single-pass membrane protein with coiled-coil domains 1
decreases expression
ISO
tebuconazole results in decreased expression of SMCO1 mRNA
CTD
PMID:30458266
NCBI chr16:32,090,298...32,093,599
Ensembl chr16:32,090,286...32,093,599
G
Snai1
snail family zinc finger 1
increases expression
ISO
tebuconazole results in increased expression of SNAI1 mRNA
CTD
PMID:30458266
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
G
Spdef
SAM pointed domain containing ets transcription factor
decreases expression
ISO
tebuconazole results in decreased expression of SPDEF mRNA
CTD
PMID:30458266
NCBI chr17:27,933,416...27,949,977
Ensembl chr17:27,933,326...27,947,929
G
Spi1
Spi-1 proto-oncogene
decreases expression
ISO
tebuconazole results in decreased expression of SPI1 mRNA
CTD
PMID:30458266
NCBI chr 2:90,912,750...90,946,104
Ensembl chr 2:90,912,735...90,946,101
G
Sqle
squalene epoxidase
increases expression
ISO
tebuconazole results in increased expression of SQLE mRNA
CTD
PMID:30458266
NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions increases expression
ISO
[propiconazole co-treated with tebuconazole] results in increased expression of SREBF1 mRNA tebuconazole results in increased expression of SREBF1 mRNA
CTD
PMID:30989312
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Srms
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
decreases expression
ISO
tebuconazole results in decreased expression of SRMS mRNA
CTD
PMID:30458266
NCBI chr 2:180,847,356...180,854,964
Ensembl chr 2:180,847,355...180,854,978
G
Stum
mechanosensory transduction mediator
decreases expression
ISO
tebuconazole results in decreased expression of STUM mRNA
CTD
PMID:30458266
NCBI chr 1:180,259,938...180,311,199
Ensembl chr 1:180,259,952...180,311,069
G
Sult1e1
sulfotransferase family 1E, member 1
decreases expression
ISO
tebuconazole results in decreased expression of SULT1E1 mRNA
CTD
PMID:30458266
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Syngap1
synaptic Ras GTPase activating protein 1 homolog (rat)
decreases expression
ISO
tebuconazole results in decreased expression of SYNGAP1 mRNA
CTD
PMID:30458266
NCBI chr17:27,160,186...27,191,408
Ensembl chr17:27,160,227...27,191,408
G
Tbx2
T-box 2
decreases expression
ISO
tebuconazole results in decreased expression of TBX2 mRNA
CTD
PMID:30458266
NCBI chr11:85,723,441...85,732,774
Ensembl chr11:85,723,377...85,732,774
G
Tbx21
T-box 21
increases expression
ISO
tebuconazole results in increased expression of TBX21 mRNA
CTD
PMID:30458266
NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
tebuconazole results in decreased expression of TERF1 mRNA
CTD
PMID:30458266
NCBI chr 1:15,875,634...15,914,283
Ensembl chr 1:15,875,870...15,914,276
G
Tex21
testis expressed gene 21
decreases expression
ISO
tebuconazole results in decreased expression of TEX21P mRNA
CTD
PMID:30458266
NCBI chr12:76,245,460...76,293,532
Ensembl chr12:76,245,460...76,293,520
G
Tex38
testis expressed 38
increases expression
ISO
tebuconazole results in increased expression of TEX38 mRNA
CTD
PMID:30458266
NCBI chr 4:115,633,178...115,639,925
Ensembl chr 4:115,637,031...115,638,215
G
Tfrc
transferrin receptor
decreases expression
ISO
tebuconazole results in decreased expression of TFRC mRNA; tebuconazole results in decreased expression of TFRC protein
CTD
PMID:33049508
NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
increases expression
ISO
tebuconazole results in increased expression of TICRR mRNA
CTD
PMID:30458266
NCBI chr 7:79,309,944...79,347,896
Ensembl chr 7:79,309,944...79,347,896
G
Timp1
tissue inhibitor of metalloproteinase 1
increases expression
ISO
tebuconazole results in increased expression of TIMP1 mRNA
CTD
PMID:26852204
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Timp2
tissue inhibitor of metalloproteinase 2
increases expression
ISO
tebuconazole results in increased expression of TIMP2 mRNA
CTD
PMID:26852204
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
G
Tm6sf2
transmembrane 6 superfamily member 2
decreases expression
ISO
tebuconazole results in decreased expression of TM6SF2 mRNA
CTD
PMID:30458266
NCBI chr 8:70,525,574...70,532,716
Ensembl chr 8:70,525,574...70,532,716
G
Tmed3
transmembrane p24 trafficking protein 3
decreases expression
ISO
tebuconazole results in decreased expression of TMED3 mRNA
CTD
PMID:30458266
NCBI chr 9:89,581,256...89,587,096
Ensembl chr 9:89,581,259...89,587,121
G
Tmem106b
transmembrane protein 106B
increases expression
ISO
tebuconazole results in increased expression of TMEM106B mRNA
CTD
PMID:30458266
NCBI chr 6:13,069,758...13,089,268
Ensembl chr 6:13,069,758...13,089,268
G
Tmem125
transmembrane protein 125
decreases expression
ISO
tebuconazole results in decreased expression of TMEM125 mRNA
CTD
PMID:30458266
NCBI chr 4:118,398,138...118,402,110
Ensembl chr 4:118,398,138...118,401,241
G
Tmem179
transmembrane protein 179
decreases expression
ISO
tebuconazole results in decreased expression of TMEM179 mRNA
CTD
PMID:30458266
NCBI chr12:112,466,618...112,477,594
Ensembl chr12:112,466,623...112,483,181
G
Tmem97
transmembrane protein 97
increases expression
ISO
tebuconazole results in increased expression of TMEM97 mRNA
CTD
PMID:30458266
NCBI chr11:78,432,643...78,441,561
Ensembl chr11:78,432,643...78,441,603
G
Tnf
tumor necrosis factor
decreases expression
ISO
tebuconazole results in decreased expression of TNF mRNA
CTD
PMID:26852204
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnni1
troponin I, skeletal, slow 1
decreases expression
ISO
tebuconazole results in decreased expression of TNNI1 mRNA
CTD
PMID:30458266
NCBI chr 1:135,709,252...135,738,727
Ensembl chr 1:135,707,172...135,738,727
G
Tnnt3
troponin T3, skeletal, fast
decreases expression
ISO
tebuconazole results in decreased expression of TNNT3 mRNA
CTD
PMID:30458266
NCBI chr 7:142,052,530...142,069,746
Ensembl chr 7:142,052,573...142,069,746
G
Tnrc18
trinucleotide repeat containing 18
decreases expression
ISO
tebuconazole results in decreased expression of TNRC18 mRNA
CTD
PMID:30458266
NCBI chr 5:142,710,357...142,812,386
Ensembl chr 5:142,710,416...142,803,417
G
Tomt
transmembrane O-methyltransferase
decreases expression
ISO
tebuconazole results in decreased expression of LRTOMT mRNA
CTD
PMID:30458266
NCBI chr 7:101,549,010...101,555,572
Ensembl chr 7:101,547,577...101,555,566
G
Tpbgl
trophoblast glycoprotein-like
decreases expression
ISO
tebuconazole results in decreased expression of TPBGL mRNA
CTD
PMID:30458266
NCBI chr 7:99,273,274...99,276,310
Ensembl chr 7:99,273,289...99,276,310
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
decreases expression
ISO
tebuconazole results in decreased expression of TRPV6 mRNA
CTD
PMID:30458266
NCBI chr 6:41,597,553...41,613,339
Ensembl chr 6:41,597,558...41,613,339
G
Try4
trypsin 4
decreases expression
ISO
tebuconazole results in decreased expression of PRSS3 mRNA
CTD
PMID:30458266
NCBI chr 6:41,279,206...41,282,467
Ensembl chr 6:41,279,203...41,282,466
G
Tstd2
thiosulfate sulfurtransferase (rhodanese)-like domain containing 2
decreases expression
ISO
tebuconazole results in decreased expression of TSTD2 mRNA
CTD
PMID:30458266
NCBI chr 4:46,114,746...46,138,725
Ensembl chr 4:46,114,746...46,138,694
G
Txnl1
thioredoxin-like 1
decreases expression
ISO
tebuconazole results in decreased expression of TXNL1 mRNA
CTD
PMID:30458266
NCBI chr18:63,795,872...63,825,535
Ensembl chr18:63,794,165...63,841,872
G
Ubl4b
ubiquitin-like 4B
decreases expression
ISO
tebuconazole results in decreased expression of UBL4B mRNA
CTD
PMID:30458266
NCBI chr 3:107,461,014...107,462,389
Ensembl chr 3:107,461,003...107,462,389
G
Ubr4
ubiquitin protein ligase E3 component n-recognin 4
decreases expression
ISO
tebuconazole results in decreased expression of UBR4 mRNA
CTD
PMID:30458266
NCBI chr 4:139,107,970...139,216,844
Ensembl chr 4:139,079,920...139,216,899
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases expression
ISO
tebuconazole results in increased expression of UGT1A1 mRNA
CTD
PMID:30458266
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ulk1
unc-51 like kinase 1
multiple interactions
EXP
[tebuconazole co-treated with Econazole] results in increased phosphorylation of ULK1 protein; dorsomorphin inhibits the reaction [[tebuconazole co-treated with Econazole] results in increased phosphorylation of ULK1 protein]
CTD
PMID:30698772
NCBI chr 5:110,932,355...110,957,991
Ensembl chr 5:110,932,354...110,957,963
G
Vegfc
vascular endothelial growth factor C
decreases expression
ISO
tebuconazole results in decreased expression of VEGFC mRNA
CTD
PMID:26852204
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
G
Wdr37
WD repeat domain 37
decreases expression
ISO
tebuconazole results in decreased expression of WDR37 mRNA
CTD
PMID:30458266
NCBI chr13:8,853,002...8,922,136
Ensembl chr13:8,853,004...8,921,945
G
Wdr38
WD repeat domain 38
decreases expression
ISO
tebuconazole results in decreased expression of WDR38 mRNA
CTD
PMID:30458266
NCBI chr 2:38,888,287...38,891,600
Ensembl chr 2:38,887,488...38,896,180
G
Wdr5b
WD repeat domain 5B
decreases expression
ISO
tebuconazole results in decreased expression of WDR5B mRNA
CTD
PMID:30458266
NCBI chr16:35,861,560...35,863,344
Ensembl chr16:35,861,560...35,864,298
G
Wfdc2
WAP four-disulfide core domain 2
decreases expression
ISO
tebuconazole results in decreased expression of WFDC2 mRNA
CTD
PMID:30458266
NCBI chr 2:164,404,635...164,410,430
Ensembl chr 2:164,404,333...164,410,430
G
Wnt1
wingless-type MMTV integration site family, member 1
decreases expression
ISO
tebuconazole results in decreased expression of WNT1 mRNA
CTD
PMID:30458266
NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718
G
Wnt10a
wingless-type MMTV integration site family, member 10A
decreases expression
ISO
tebuconazole results in decreased expression of WNT10A mRNA
CTD
PMID:30458266
NCBI chr 1:74,831,178...74,843,335
Ensembl chr 1:74,830,675...74,843,338
G
Zfp7
zinc finger protein 7
decreases expression
ISO
tebuconazole results in decreased expression of ZNF7 mRNA
CTD
PMID:30458266
NCBI chr15:76,763,440...76,786,089
Ensembl chr15:76,763,459...76,776,595
G
Zfp956
zinc finger protein 956
decreases expression
ISO
tebuconazole results in decreased expression of ZNF835 mRNA
CTD
PMID:30458266
NCBI chr 6:47,930,324...47,942,234
Ensembl chr 6:47,930,324...47,942,234
G
Zg16
zymogen granule protein 16
decreases expression
ISO
tebuconazole results in decreased expression of ZG16 mRNA
CTD
PMID:30458266
NCBI chr 7:126,649,328...126,651,847
Ensembl chr 7:126,649,328...126,686,500
G
Zscan12
zinc finger and SCAN domain containing 12
decreases expression
ISO
tebuconazole results in decreased expression of ZSCAN12 mRNA
CTD
PMID:30458266
NCBI chr13:21,546,982...21,556,472
Ensembl chr13:21,546,990...21,556,459
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all